2017 Q2 Form 10-Q Financial Statement

#000156459017015153 Filed on August 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $3.693B $3.273B
YoY Change 12.83% 1.27%
Cost Of Revenue $1.319B $1.266B
YoY Change 4.19% -6.29%
Gross Profit $2.374B $2.007B
YoY Change 18.29% 6.7%
Gross Profit Margin 64.28% 61.32%
Selling, General & Admin $434.0M $454.0M
YoY Change -4.41% -3.4%
% of Gross Profit 18.28% 22.62%
Research & Development $378.0M $341.0M
YoY Change 10.85% 6.56%
% of Gross Profit 15.92% 16.99%
Depreciation & Amortization $225.0M $242.0M
YoY Change -7.02% -16.84%
% of Gross Profit 9.48% 12.06%
Operating Expenses $891.0M $874.0M
YoY Change 1.95% 0.46%
Operating Profit $1.480B $1.131B
YoY Change 30.86% 11.98%
Interest Expense -$20.00M -$21.00M
YoY Change -4.76% -12.5%
% of Operating Profit -1.35% -1.86%
Other Income/Expense, Net $26.00M -$8.000M
YoY Change -425.0% -366.67%
Pretax Income $1.486B $1.102B
YoY Change 34.85% 11.43%
Income Tax $430.0M $283.0M
% Of Pretax Income 28.94% 25.68%
Net Earnings $1.056B $819.0M
YoY Change 28.94% 17.67%
Net Earnings / Revenue 28.59% 25.02%
Basic Earnings Per Share $1.05 $0.81
Diluted Earnings Per Share $1.03 $0.79
COMMON SHARES
Basic Shares Outstanding 994.0M
Diluted Shares Outstanding 1.015B

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.984B $2.539B
YoY Change 17.53% -23.2%
Cash & Equivalents $1.140B $1.235B
Short-Term Investments $1.844B $1.304B
Other Short-Term Assets $1.111B $926.0M
YoY Change 19.98% -35.47%
Inventory $1.947B $1.876B
Prepaid Expenses
Receivables $1.469B $1.348B
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.511B $6.689B
YoY Change 12.29% -17.01%
LONG-TERM ASSETS
Property, Plant & Equipment $2.514B $2.557B
YoY Change -1.68% -4.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $273.0M $224.0M
YoY Change 21.88% -1.75%
Other Assets $559.0M $385.0M
YoY Change 45.19% -1.79%
Total Long-Term Assets $8.927B $9.004B
YoY Change -0.86% -4.94%
TOTAL ASSETS
Total Short-Term Assets $7.511B $6.689B
Total Long-Term Assets $8.927B $9.004B
Total Assets $16.44B $15.69B
YoY Change 4.75% -10.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $450.0M $416.0M
YoY Change 8.17% -0.24%
Accrued Expenses $842.0M $880.0M
YoY Change -4.32% -2.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $499.0M $637.0M
YoY Change -21.66% -63.6%
Total Short-Term Liabilities $1.877B $1.991B
YoY Change -5.73% -37.64%
LONG-TERM LIABILITIES
Long-Term Debt $3.084B $2.975B
YoY Change 3.66% -5.07%
Other Long-Term Liabilities $736.0M $725.0M
YoY Change 1.52% 12.4%
Total Long-Term Liabilities $3.820B $3.700B
YoY Change 3.24% 18.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.877B $1.991B
Total Long-Term Liabilities $3.820B $3.700B
Total Liabilities $5.730B $5.731B
YoY Change -0.02% -21.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.71B $9.962B
YoY Change
Total Liabilities & Shareholders Equity $16.44B $15.69B
YoY Change 4.75% -10.49%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $1.056B $819.0M
YoY Change 28.94% 17.67%
Depreciation, Depletion And Amortization $225.0M $242.0M
YoY Change -7.02% -16.84%
Cash From Operating Activities $917.0M $1.109B
YoY Change -17.31% 35.24%
INVESTING ACTIVITIES
Capital Expenditures -$151.0M -$158.0M
YoY Change -4.43% 26.4%
Acquisitions
YoY Change
Other Investing Activities $143.0M $223.0M
YoY Change -35.87% -555.1%
Cash From Investing Activities -$8.000M $65.00M
YoY Change -112.31% -137.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $375.0M $1.000B
YoY Change -62.5%
Cash From Financing Activities -842.0M -1.220B
YoY Change -30.98% 73.3%
NET CHANGE
Cash From Operating Activities 917.0M 1.109B
Cash From Investing Activities -8.000M 65.00M
Cash From Financing Activities -842.0M -1.220B
Net Change In Cash 67.00M -46.00M
YoY Change -245.65% -20.69%
FREE CASH FLOW
Cash From Operating Activities $917.0M $1.109B
Capital Expenditures -$151.0M -$158.0M
Free Cash Flow $1.068B $1.267B
YoY Change -15.71% 34.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
3273000000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
3693000000
us-gaap Sales Revenue Net
SalesRevenueNet
6281000000
us-gaap Cost Of Revenue
CostOfRevenue
2577000000
us-gaap Sales Revenue Net
SalesRevenueNet
7095000000
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
1319000000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
1266000000
CY2017Q2 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
28000000
CY2017Q2 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
635000000
CY2016Q4 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
554000000
us-gaap Depreciation
Depreciation
273000000
us-gaap Depreciation
Depreciation
316000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
159000000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-45000000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-35000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
200000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
176000000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
157000000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
185000000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12000000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-35000000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-66000000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1000000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-225000000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-175000000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-236000000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
106000000
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
5000000
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
32000000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1712000000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1762000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
278000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
40000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1887000000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1193000000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2385000000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2110000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-3000000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
259000000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
638000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
605000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
499000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
625000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000000
us-gaap Payments Of Dividends
PaymentsOfDividends
998000000
us-gaap Payments Of Dividends
PaymentsOfDividends
765000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1200000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1157000000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
245000000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
261000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1985000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
235000000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1000000000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1235000000
us-gaap Restructuring Charges
RestructuringCharges
7000000
us-gaap Payments For Restructuring
PaymentsForRestructuring
10000000
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
1000000
CY2017Q2 us-gaap Restructuring Reserve
RestructuringReserve
36000000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10000000
CY2016Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10000000
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1046000000
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
809000000
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21000000
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16000000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
20000000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
19000000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2033000000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1511000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16000000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16000000
txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.31
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
40000000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017Q2 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
458000000
CY2016Q2 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
325000000
txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
840000000
txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
606000000
CY2016Q2 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
42000000
txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
152000000
txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
84000000
CY2017Q2 txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.31
CY2016Q2 txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.30
txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.30
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.29
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
CY2017Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1140000000
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1154000000
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2784000000
CY2017Q2 txn Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
10000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2940000000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1835000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2940000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1676000000
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000000
CY2017Q2 us-gaap Commercial Paper
CommercialPaper
0
CY2017Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
250000000
CY2017Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
375000000
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3625000000
CY2016Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
16000000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
3609000000
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
10938502
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
27000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
282000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2165000000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9. <font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Indemnification guarantees</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warranty costs/product liabilities</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the&#160;likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">General</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p></div>
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Indemnification guarantees</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warranty costs/product liabilities</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the&#160;likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.</p></div>
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3600000000
CY2017Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
17000000
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
3583000000
CY2017Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2057729

Files In Submission

Name View Source Status
0001564590-17-015153-index-headers.html Edgar Link pending
0001564590-17-015153-index.html Edgar Link pending
0001564590-17-015153.txt Edgar Link pending
0001564590-17-015153-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
txn-10q_20170630.htm Edgar Link pending
txn-20170630.xml Edgar Link completed
txn-20170630.xsd Edgar Link pending
txn-20170630_cal.xml Edgar Link unprocessable
txn-20170630_def.xml Edgar Link unprocessable
txn-20170630_lab.xml Edgar Link unprocessable
txn-20170630_pre.xml Edgar Link unprocessable
txn-ex31a_7.htm Edgar Link pending
txn-ex31b_8.htm Edgar Link pending
txn-ex32a_9.htm Edgar Link pending
txn-ex32b_6.htm Edgar Link pending